Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 520.00
Bid: 520.00
Ask: 530.00
Change: -12.00 (-2.26%)
Spread: 10.00 (1.923%)
Open: 526.00
High: 530.00
Low: 518.00
Prev. Close: 532.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Dec 2017 07:00

RNS Number : 9545Z
Zotefoams PLC
21 December 2017
 

Thursday 21 December 2017

 

Zotefoams plc

("Zotefoams" or the "Company" or "Group")

 

Directorate change

 

Zotefoams plc, a world leader in cellular materials technology, is pleased to announce the appointment of Jonathan Carling as a Non-Executive Director with effect from 2 January 2018. Jonathan will become a member of the Audit, Nominations and Remuneration Committees on the same date.

Jonathan is currently the CEO of Tokamak Energy, a technology business developing a faster route to fusion power. Jonathan, who was previously COO, Civil Large Engines at Rolls Royce plc, COO at Aston Martin Lagonda Limited, and Chief Engineer with Jaguar Landrover Limited, brings extensive engineering, operational and business experience to Zotefoams. He was also a Non-Executive Director of Aga Rangemasters plc between 2011 and 2015. There is no further information to disclose pursuant to LR 9.6.13 of the Listing Rules.

After ten years on the Zotefoams Board, Richard Clowes, Non-Executive Director and Senior Independent Director will be not be seeking re-election to the Board at the AGM in May 2018.

Steve Good, Chairman of Zotefoams plc, said:

"We are delighted to welcome Jonathan to the Board. His background in engineering and operations gained in high quality aerospace and automotive businesses will be of great value to the Board as the Group continues to invest and pursue its ambitious strategy for growth."

 

 

Enquiries:

Zotefoams plc

 

+44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

 

IFC Advisory

 

+44 (0) 203 934 6630

Graham Herring

Miles Nolan

 

 

 

About Zotefoams plc

 

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE® polyolefin and ZOTEK® high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®).

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAURAURBVAUUAA
Date   Source Headline
21st Dec 20055:32 pmRNSHolding(s) in Company
15th Dec 20057:00 amRNSPeriod End Trading Update
12th Dec 20054:12 pmRNSBlocklisting Interim Review
22nd Nov 200511:37 amRNSDirector/PDMR Shareholding
2nd Nov 20057:01 amRNSTrading Statement
26th Aug 200512:00 pmRNSUpdate on Directorate
18th Aug 20057:00 amRNSUpdate on Discussions
18th Aug 20057:00 amRNSInterim Results
3rd Aug 200511:23 amRNSRule 8.1- Zotefoams PLC
2nd Aug 200511:14 amRNSRule 8.1- Zotefoams PLC
20th Jul 200511:49 amRNSRule 8.1- Zotefoams PLC
9th Jun 20058:36 amRNSAdditional Listing
3rd May 20055:00 pmRNSHolding(s) in Company
28th Apr 20057:03 amRNSAGM Statement
24th Mar 200511:59 amRNSDocuments on Display
8th Mar 20057:01 amRNSFinal Results
17th Jan 200511:43 amRNSRule 2.10 Announcement
14th Jan 200510:19 amRNSStatement re Possible Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.